Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesLipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly: Opportunities and Challenges
Drugs & Aging, 10/26/09
Robinson JG – Moderate–dose statins have been shown to be effective and safe in properly selected elderly patients up to the age of 80 years. High–dose statins have also been shown to be effective and reasonably safe in patients without significant co–morbidities up to the age of 75 years. With advancing age, the potential for benefit from cholesterol–lowering treatment needs to be weighed against the increasing risk of muscle and hepatic toxicity, as well as competing causes of morbidity and mortality.
Related Articles
Management of hypertension in the elderly patient
Clinical Interventions in Aging, 10/01/09
Relevance Score: 97%
Acute medical management of the non-ST-segment elevation acute coronary syndromes (NSTE-ACS) in older patients
Archives of Gerontology and Geriatrics, 10/14/09
Relevance Score: 95%
Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study
Cardiovascular Diabetology, 11/03/09
Relevance Score: 93%
Impact of Decision Support in Electronic Medical Records on Lipid Management in Primary Care
Population Health Management, 10/27/09
Relevance Score: 93%
Complementary/Alternative Medicine in the context of prevention of disease and maintenance of health
Preventive Medicine, 10/08/09
Relevance Score: 93%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Beta-Adrenergic Antagonists in Hypertension: A Review of the Evidence
Annals of Pharmacotherapy, 11/25/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Sponsor
Article Search
Sponsor